sparfloxacin
Selected indexed studies
- Sparfloxacin: a review. (Clin Ther, 2000) [PMID:10823360]
- Clinical pharmacokinetics of sparfloxacin. (Clin Pharmacokinet, 1993) [PMID:8287631]
- Levofloxacin and sparfloxacin: new quinolone antibiotics. (Ann Pharmacother, 1998) [PMID:9533064]
_Worker-drafted node — pending editorial review._
Connections
sparfloxacin is a side effect of
Sources
- Sparfloxacin: a review. (2000) pubmed
- Clinical pharmacokinetics of sparfloxacin. (1993) pubmed
- Levofloxacin and sparfloxacin: new quinolone antibiotics. (1998) pubmed
- Sparfloxacin ameliorates DSS-induced ulcerative colitis by suppressing cellular senescence, JAK/NF-κB signaling pathway and modulation of the gut microbiota-metabolite axis. (2025) pubmed
- Sparfloxacin and other new fluoroquinolones. (1992) pubmed
- Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections. (1997) pubmed
- Sparfloxacin in tuberculosis. (1998) pubmed
- [Sparfloxacin]. (1998) pubmed
- Sparfloxacin-associated corneal epithelial toxicity. (2014) pubmed
- Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group. (1996) pubmed